0VAG.LSE Novanta Inc.

Technology Oil, Gas & Consumable Fuels London Exchange
- USD
Market cap
-
P/E
91.5x
P/B
-
ROE
4.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0VAG.LSE undervalued?

Graham number

The Graham number of Novanta Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Novanta Inc. fundamental analysis

No fundamental analysis for Novanta Inc. yet.

Novanta Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Novanta Inc.

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision m…

Full company profile